SE0000933D0 - Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds - Google Patents

Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds

Info

Publication number
SE0000933D0
SE0000933D0 SE0000933A SE0000933A SE0000933D0 SE 0000933 D0 SE0000933 D0 SE 0000933D0 SE 0000933 A SE0000933 A SE 0000933A SE 0000933 A SE0000933 A SE 0000933A SE 0000933 D0 SE0000933 D0 SE 0000933D0
Authority
SE
Sweden
Prior art keywords
producing
substituted
intermediate compounds
nicotine derivatives
compound
Prior art date
Application number
SE0000933A
Other languages
English (en)
Swedish (sv)
Inventor
Anette Johansson
Torgny Svensson
Original Assignee
Independent Pharmaceutica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Independent Pharmaceutica Ab filed Critical Independent Pharmaceutica Ab
Priority to SE0000933A priority Critical patent/SE0000933D0/xx
Publication of SE0000933D0 publication Critical patent/SE0000933D0/xx
Priority to AT01918042T priority patent/ATE273295T1/de
Priority to ES01918042T priority patent/ES2225507T3/es
Priority to TR2004/02787T priority patent/TR200402787T4/xx
Priority to JP2001568933A priority patent/JP4370073B2/ja
Priority to PT01918042T priority patent/PT1265888E/pt
Priority to CA2402748A priority patent/CA2402748C/en
Priority to DE60104825T priority patent/DE60104825T2/de
Priority to EP01918042A priority patent/EP1265888B1/en
Priority to AU2001244913A priority patent/AU2001244913B2/en
Priority to AU4491301A priority patent/AU4491301A/xx
Priority to PCT/SE2001/000599 priority patent/WO2001070730A1/en
Priority to US10/221,175 priority patent/US6747156B2/en
Priority to HK03101515.1A priority patent/HK1051854B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE0000933A 2000-03-21 2000-03-21 Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds SE0000933D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE0000933A SE0000933D0 (sv) 2000-03-21 2000-03-21 Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
US10/221,175 US6747156B2 (en) 2000-03-21 2001-03-21 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds
CA2402748A CA2402748C (en) 2000-03-21 2001-03-21 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds
ES01918042T ES2225507T3 (es) 2000-03-21 2001-03-21 Metodo para producir derivados de (s)-nicotina sustituidos en la posicion 6 y compuestos intermedios.
TR2004/02787T TR200402787T4 (tr) 2000-03-21 2001-03-21 @İkameliÁ}SBÁNikotinÁtürevleriÁveÁaraÁbileşikleriÁüretmeÁmetodu
JP2001568933A JP4370073B2 (ja) 2000-03-21 2001-03-21 ６−置換された（ｓ）−ニコチン誘導体及び中間体化合物の製造方法
PT01918042T PT1265888E (pt) 2000-03-21 2001-03-21 Processo para producao de derivados de (s)-nicotina 6-substituida e compost0s intermediarios
AT01918042T ATE273295T1 (de) 2000-03-21 2001-03-21 Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
DE60104825T DE60104825T2 (de) 2000-03-21 2001-03-21 Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
EP01918042A EP1265888B1 (en) 2000-03-21 2001-03-21 Method of producing 6-substituted ( s )-nicotine derivatives and intermediate compounds
AU2001244913A AU2001244913B2 (en) 2000-03-21 2001-03-21 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds
AU4491301A AU4491301A (en) 2000-03-21 2001-03-21 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds
PCT/SE2001/000599 WO2001070730A1 (en) 2000-03-21 2001-03-21 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds
HK03101515.1A HK1051854B (zh) 2000-03-21 2003-02-28 生產6-取代的(s)-尼古丁衍生物的方法和中間體化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000933A SE0000933D0 (sv) 2000-03-21 2000-03-21 Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds

Publications (1)

Publication Number Publication Date
SE0000933D0 true SE0000933D0 (sv) 2000-03-21

Family

ID=20278889

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000933A SE0000933D0 (sv) 2000-03-21 2000-03-21 Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds

Country Status (13)

Country Link
US (1) US6747156B2 (xx)
EP (1) EP1265888B1 (xx)
JP (1) JP4370073B2 (xx)
AT (1) ATE273295T1 (xx)
AU (2) AU2001244913B2 (xx)
CA (1) CA2402748C (xx)
DE (1) DE60104825T2 (xx)
ES (1) ES2225507T3 (xx)
HK (1) HK1051854B (xx)
PT (1) PT1265888E (xx)
SE (1) SE0000933D0 (xx)
TR (1) TR200402787T4 (xx)
WO (1) WO2001070730A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005232129A (ja) * 2004-02-23 2005-09-02 Air Water Chemical Inc 芳香族性アセチレン類の製造方法
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2007070682A2 (en) 2005-12-15 2007-06-21 Massachusetts Institute Of Technology System for screening particles
WO2008105773A2 (en) 2006-03-31 2008-09-04 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
CA2652280C (en) 2006-05-15 2014-01-28 Massachusetts Institute Of Technology Polymers for functional particles
WO2007150030A2 (en) * 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
WO2008019142A2 (en) * 2006-08-04 2008-02-14 Massachusetts Institute Of Technology Oligonucleotide systems for targeted intracellular delivery
US20090074828A1 (en) * 2007-04-04 2009-03-19 Massachusetts Institute Of Technology Poly(amino acid) targeting moieties
MX350501B (es) 2007-10-12 2017-09-07 Massachusetts Inst Technology Nanotecnologia de vacuna.
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8343497B2 (en) * 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US20110293701A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
TWI455722B (zh) * 2010-06-04 2014-10-11 Pfizer Vaccines Llc 用於預防或治療菸鹼成癮之共軛體
AU2014210682B2 (en) * 2010-06-04 2015-10-08 Pfizer Vaccines Llc Conjugates for the prevention or treatment of nicotine addiction
WO2012061717A1 (en) 2010-11-05 2012-05-10 Selecta Biosciences, Inc. Modified nicotinic compounds and related methods
CN109172819A (zh) 2011-07-29 2019-01-11 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
US9303013B2 (en) 2014-05-16 2016-04-05 Pfizer Inc. Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4155909A (en) * 1977-06-13 1979-05-22 Philip Morris Incorporated 2-Alkyl nicotinoids and processes for their production
US4465833A (en) * 1980-10-15 1984-08-14 Hughes Aircraft Company Process for preparing ethynylated benzoic acid derivatives
DE4020053A1 (de) * 1990-01-31 1991-08-01 Bayer Ag Verfahren zur herstellung von 2-chlor-5-methyl-pyridin
DE4020052A1 (de) * 1990-06-23 1992-01-02 Bayer Ag Verfahren zur herstellung von 2-chlor-5-methyl-pyridin
US5502194A (en) * 1992-02-19 1996-03-26 Bayer Aktiengesellschaft Process for the preparation of 2-halogeno-pyridine derivatives
KR100309871B1 (ko) 1999-02-24 2001-10-29 윤종용 (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법
SE9801923D0 (sv) 1998-05-29 1998-05-29 Independent Pharmaceutical Ab Nicotine vaccine
US20040079259A1 (en) 2002-10-29 2004-04-29 Felix Manig Method of manufacturing cementitious materials
FR2849657B1 (fr) 2003-01-03 2005-07-15 Arjo Wiggins Feuille possedant un aspect iridescent, et son procede de fabrication

Also Published As

Publication number Publication date
CA2402748A1 (en) 2001-09-27
WO2001070730A1 (en) 2001-09-27
ATE273295T1 (de) 2004-08-15
US6747156B2 (en) 2004-06-08
PT1265888E (pt) 2004-11-30
AU4491301A (en) 2001-10-03
HK1051854B (zh) 2005-02-18
HK1051854A1 (en) 2003-08-22
EP1265888B1 (en) 2004-08-11
AU2001244913B2 (en) 2005-08-11
ES2225507T3 (es) 2005-03-16
DE60104825T2 (de) 2005-09-29
JP4370073B2 (ja) 2009-11-25
EP1265888A1 (en) 2002-12-18
TR200402787T4 (tr) 2004-11-22
CA2402748C (en) 2010-02-16
US20030187270A1 (en) 2003-10-02
JP2003529568A (ja) 2003-10-07
DE60104825D1 (de) 2004-09-16

Similar Documents

Publication Publication Date Title
SE0000933D0 (sv) Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
NO20062644L (no) DPP-IV inhibitorer
BR0313342A (pt) Método de preparação de compostos
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
CY1107001T1 (el) Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες
ATE389635T1 (de) Pharmazeutisch wirksame piperidinderivate
BRPI0516904A (pt) processo para a preparação de um derivado de 2-etilaminopiridina e composto
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
CY1105666T1 (el) Διεργασια για την παρασκευη αζακυκλοαλκανοϋλαμινοθειαζολων
BR0307303A (pt) Processo para a fabricação de inibidores da hmg-coa redutase
ATE237612T1 (de) Benzofuranderivate
EA200300629A1 (ru) Конденсированные производные пурина как антагонисты рецепторов аденозина a
MY138826A (en) 2,7-substituted indoles
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
ES2159488A1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifugica.
YU46706B (sh) Postupak za dobijanje amidnih jedinjenja
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
DE60101784D1 (de) Synthese von wasserlöslischem 9-dihydroplacitaxel derivate aus 9-dihydro-13-acetylbacchatin iii
BRPI0314501C8 (pt) processo para a preparação de um derivado de 2-aminometilpiridina e processo para a preparação de um derivado de cloridrato de éster de glicina piridina
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
MXPA03012073A (es) Amidoderivados heterociclicos.
PA8558901A1 (es) Nuevos compuestos hexaciclicos